PDGFRα/β heterodimer activation negatively affects downstream ERK1/2 signaling and cellular proliferation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40404618.
- Also identified by DOI 10.1038/s41467-025-59938-1 and PMC identifier 12098797.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The platelet-derived growth factor receptor (PDGFR) family of receptor tyrosine kinases consists of two receptors, PDGFRα and PDGFRβ, that homodimerize and heterodimerize upon ligand binding. Here, we tested the hypothesis that differential internalization and trafficking dynamics of the various PDGFR dimers underlie differences in downstream intracellular signaling and cellular behavior. Using a bimolecular fluorescence complementation approach, we demonstrated that PDGFRα/β heterodimers are rapidly internalized into early endosomes. We showed that PDGFRα/β heterodimer activation does not induce downstream phosphorylation of ERK1/2 and significantly inhibits cell proliferation. Further, we identified MYO1D as a protein that preferentially binds PDGFRα/β heterodimers and demonstrated that knockdown of MYO1D leads to retention of PDGFRα/β heterodimers at the plasma membrane, increased phosphorylation of ERK1/2 and increased cell proliferation. Collectively, our findings impart valuable insight into the molecular mechanisms by which specificity is introduced downstream of PDGFR activation to differentially propagate signaling and generate distinct cellular responses.
Medical subject headings
- Cell Proliferation
- Receptor, Platelet-Derived Growth Factor beta
- Receptor, Platelet-Derived Growth Factor alpha
- MAP Kinase Signaling System
- Mitogen-Activated Protein Kinase 3